Investigation into ubiquitin signalling in response to cisplatin
Cisplatin is an anti-cancer drug that acts by introducing toxic DNA interstrand crosslinks into proliferating cells, causing both cytostatic and cytotoxic effects. Although various models of the interstrand crosslink (ICL) response have been proposed, none of them are complete and much still remains...
Main Author: | Carroll, Eilis |
---|---|
Published: |
University of Dundee
2014
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.613613 |
Similar Items
-
How the ubiquitin system triggers the activation of the MyD88 signalling network
by: Strickson, Sam
Published: (2015) -
Responses of in vitro cultured human cells to cisplatin with respect to p53 expression levels
by: Hogwood, Caterine Elizabeth
Published: (2009) -
Investigating the signalling pathways that regulate contact inhibition of locomotion
by: Kadir, Shereen
Published: (2009) -
The sensitisation of TRPV1 mediated responses by prostaglandin and bradykinin and the signalling pathways involved
by: Aldossary, Sara Abdulrahman M.
Published: (2015) -
A systems modelling study of the integrated stress/damage response and nutrient signalling network
by: Hall, Philip
Published: (2016)